Your browser doesn't support javascript.
loading
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial.
Cukierman-Yaffe, Tali; Gerstein, Hertzel C; Colhoun, Helen M; Diaz, Rafael; García-Pérez, Luis-Emilio; Lakshmanan, Mark; Bethel, Angelyn; Xavier, Denis; Probstfield, Jeffrey; Riddle, Matthew C; Rydén, Lars; Atisso, Charles Messan; Hall, Stephanie; Rao-Melacini, Purnima; Basile, Jan; Cushman, William C; Franek, Edward; Keltai, Matyas; Lanas, Fernando; Leiter, Lawrence A; Lopez-Jaramillo, Patricio; Pirags, Valdis; Pogosova, Nana; Raubenheimer, Peter J; Shaw, Jonathan E; Sheu, Wayne H-H; Temelkova-Kurktschiev, Theodora.
Afiliação
  • Cukierman-Yaffe T; Endocrinology Institute, Gertner Institute, Sheba Medical Center, Ramat-Gan, Israel; Epidemiology Department, Sackler School of Medicine, Herceg Institute of Aging, Tel Aviv University, Tel Aviv, Israel.
  • Gerstein HC; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. Electronic address: gerstein@mcmaster.ca.
  • Colhoun HM; University of Edinburgh, Edinburgh, UK.
  • Diaz R; Estudios Clínicos Latino América, Rosario, Argentina.
  • García-Pérez LE; Eli Lilly and Company, Indianapolis, IN, USA.
  • Lakshmanan M; Eli Lilly and Company, Indianapolis, IN, USA.
  • Bethel A; Eli Lilly and Company, Indianapolis, IN, USA.
  • Xavier D; St John's Medical College, Bangalore, India.
  • Probstfield J; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Riddle MC; Department of Medicine, Oregon Health and Science University Portland, OR, USA.
  • Rydén L; Department of Medicine K2, Karolinska Institutet, Stockholm, Sweden.
  • Atisso CM; Eli Lilly and Company, Indianapolis, IN, USA.
  • Hall S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Rao-Melacini P; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Basile J; Medical University of South Carolina, Charleston, SC, USA.
  • Cushman WC; Memphis Veterans Affairs Medical Center, Memphis, TN, USA.
  • Franek E; Mossakowski Medical Research Centre, Polish Academy of Sciences and Central Clinical Hospital, Warsaw, Poland.
  • Keltai M; Semmelweis University, Hungarian Institute of Cardiology, Budapest, Hungary.
  • Lanas F; Universidad de La Frontera, Temuco, Chile.
  • Leiter LA; Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Lopez-Jaramillo P; Masira Research Institute, Medical School, Universidad de Santander, Bucaramanga, Colombia.
  • Pirags V; Latvijas Universitate, Riga, Latvia.
  • Pogosova N; National Medical Research Center of Cardiology, Moscow, Russia.
  • Raubenheimer PJ; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Shaw JE; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Sheu WH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Temelkova-Kurktschiev T; Robert Koch Medical Center, Sofia, Bulgaria.
Lancet Neurol ; 19(7): 582-590, 2020 07.
Article em En | MEDLINE | ID: mdl-32562683

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_diabetes / 6_endocrine_disorders / 6_mental_health_behavioral_disorders Assunto principal: Proteínas Recombinantes de Fusão / Fragmentos Fc das Imunoglobulinas / Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon / Disfunção Cognitiva / Hipoglicemiantes Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_diabetes / 6_endocrine_disorders / 6_mental_health_behavioral_disorders Assunto principal: Proteínas Recombinantes de Fusão / Fragmentos Fc das Imunoglobulinas / Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon / Disfunção Cognitiva / Hipoglicemiantes Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Israel
...